Profile: Cambridge Neuroscience, Inc. is a biopharmaceutical company. We specialize in the development of proprietary pharmaceuticals to prevent & treat severe disorders of the nervous system. We develop ion-channel blockers to prevent or treat brain damage resulting from stroke and other forms of brain ischemia. We are involved in the treatment & prevention of glaucoma, spinal cord injury and Parkinson's disease. We also focus on the treatment of multiple sclerosis and peripheral neuropathy.